Providing for Consideration of H.R. 5819, SBIR/STTR Reauthorization Act

Floor Speech

Date: April 23, 2008
Location: Washington, DC
Issues: Science

BREAK IN TRANSCRIPT

Mr. Speaker, I thank the gentleman for the time.

Let me simply say this bill is intended to increase the small business set-aside for these research programs. That does no harm for a large agency whose budget has been rising, such as the Department of Defense, but it can do immeasurable harm to the crown jewel of our research agencies in this country, the National Institutes of Health.

If we were to do what this bill does to NIH, it would result in $187 million less being available for traditional medical research grants at medical research centers and universities. I think that that is not a good idea. The President's budget has already reduced the number of grants that NIH will be able to provide by almost 500 grants. This will add about another 500 grant reduction to the President's budget. That would mean that we would be supporting a grant level for the traditional NIH grants at about 1,100 grants fewer than was the case in 2007. I think that is a very bad idea. Therefore, when the bill comes before us, I would urge support of the Ehlers amendment, which will correct the problem with respect to the National Institutes of Health.

I know that some people will say, ``Well, we're not reducing the number of grants, we're simply shifting the nature of grants from traditional grants to small business grants.'' But the fact is that the success rate for small business grants under this bill is expected to rise to 52 percent whereas the success rate for applications for traditional NIH grants is expected to decline to 18 percent. That is a disparity that the scientific community and the country at large simply cannot afford.

NIH believes that there will not be sufficient high-quality grants under the small business set-aside to pass peer review over time, and that means they would simply have to lapse back precious research money that could be used for heart disease, for Parkinson's, for cancer, things like that.

So I would strongly urge, when this bill comes before us, to vote for the Ehlers amendment as a way to address that balance.

BREAK IN TRANSCRIPT


Source
arrow_upward